Risk factors for and characteristics of secondary primary malignancies following autologous hematopoietic cell transplant for multiple myeloma.
Study #: MM20-02a
Study Status: Published
Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: A CIBMTR analysis.
Citation
Ragon BK, Shah MV, D'Souza A, Estrada-Merly N, Gowda L, George G, de Lima M, Hashmi S, Kharfan-Dabaja MA, Majhail NS, Banerjee R, Saad A, Hildebrandt GC, Mian H, Abid MB, Battiwalla M, Lekakis LJ, Patel SS, Murthy HS, Nieto Y, Strouse C, Badawy SM, Al Hadidi S, Dholaria B, Aljurf M, Vesole DH, Lee CH, Pawarode A, Gergis U, Miller KC, Holmberg LA, Afrough A, Solh M, Munshi PN, Nishihori T, Anderson LD Jr, Wirk B, Kaur G, Qazilbash MH, Shah N, Kumar SK, Usmani SZ.
Blood Advances. 2023, Jun 27: 7(12): 7(12):2746-2757. doi: 10.1182/bloodadvances.2022009138. Epub 2023, Feb 24. PMCID:PMC10275699.
PubMed
PMID: 36827681
Abstract